Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: Effects of Blocking Blue Light at Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH [NA]

View source ↗

Summary

A West Virginia University-led clinical trial is evaluating whether blocking blue light at night improves circadian rhythm disorders in patients after CABG, AVR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: West Virginia University | Conditions: Circadian Rhythm Disorders | NA | Status: RECRUITING